LFVN | tickerfilter.com

Fundamental analysis

37%

Profitability 27%

Dept financing 14%

Liquidity 72%

Performance 44%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

-4.18%

1 Month

-16.74%

3 Months

-44.57%

6 Months

-6.47%

1 Year

102.00%

2 Year

269.00%

Key data

Stock price

$12.14

P/E Ratio

29.91

DAY RANGE

$11.74 - $12.81

EPS

$0.60

52 WEEK RANGE

$5.22 - $27.38

52 WEEK CHANGE

$99.02

MARKET CAP

219.567 M

YIELD

0.88%

SHARES OUTSTANDING

12.479 M

DIVIDEND

$0.04

EX-DIVIDEND DATE

03-03-2025

NEXT EARNINGS DATE

05-01-2025

BETA

-0.96

PUBLIC FLOAT

AVERAGE 10 VOLUME

$172,898

AVERAGE 30 VOLUME

$167,047

Company detail

CEO: Steven R. Fife
Region: US
Website: lifevantage.com
Employees: 260
IPO year: 2004

Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

LifeVantage Corporation engages in the identification, research, development, formulation, sale, and distribution of nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care products, bath and body, and targeted relief products. The company sells its products through its website, as well as through a network of independent distributors in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, and Singapore.

LFVN - Lifevantage Corp